The benefits our patients receive from Photobiomodulation (PBM) is simply, unmatched. They are complemented by LLLT's exceptional efficacy in treating Meibomian Gland Dysfunction or MGD—although global thought leaders in the scientific community have leveraged it beyond MGD to treat the ocular surface (e.g., Dry Eyes, Chalazian, Styes, Blepharitis, Demodex, Sjögren’s Syndrome).
 
LLLT is a unique, light-based photobiomodulation technology. It's been developed and patented for medical use with the technology originally employed by NASA (i.e., Low-level Laser Therapy) to treat wounds of astronauts in space.  LLLT has nothing to do with Red Light Therapy (RLT), which only acts on the surface of the skin.  Instead, Drs. Smarch & Schnurer utilize an LLLT that works beneath the skin, at biological level, generating endogenous energy through powerful LEDs stimulating ATP production in cells.

This patented PBM technology isn’t just like any other red light therapy. It's patented and certified for medical use, designed to leverage near-infrared light beams that solicit cells’ mitochondria, triggering biochemical and biophysical reactions that stimulate them to provide better protein synthesis. Thanks to this process of endogenous heating, the tear lipid layer is increased and stabilized allowing you to feel and see the difference.